Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Board of Directors

Board of Directors

Rajesh C. Shrotriya, MD
Chairman and Chief Executive Officer
Raymond W. Cohen
Stuart M. Krassner, ScD, PsyD
Luigi Lenaz MD
Anthony E. Maida III, PhD, MA, MBA
Gilles Gagnon M.Sc., MBA, ICD
Dolatrai M. Vyas PhD

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
7.60
Change:
+ 0.11
Day High:
7.66
Day Low:
7.45
Volume:
1,483,600
4:00 PM ET on Aug 28, 2015
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR